Relay Therapeutics (RLAY) EPS (Basic) (2019 - 2026)
Relay Therapeutics (RLAY) posted quarterly EPS (Basic) of -$0.44 for Q1 2026, up 4.5% year-over-year from -$0.42 in Q1 2025, and down 115.17% quarter-over-quarter from -$0.2 in Q4 2025.
Relay Therapeutics (RLAY) EPS (Basic) (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has reported EPS (Basic) for 8 consecutive years, with -$0.44 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 4.5% year-over-year to -$0.44; the TTM figure through Mar 2026 stood at -$1.46 (up 66.85% YoY), while the FY2025 annual figure was -$4.41, up 18.19% from the prior year.
- EPS (Basic) retreated to -$0.44 in Q1 2026 per RLAY's latest filing, from -$0.2 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.2 in Q4 2025 and bottomed at -$3.39 in Q4 2024.
- Historically, EPS (Basic) has averaged -$0.8 across 5 years, with a median of -$0.67 in 2022.
- Annual changes were most pronounced in 2024 — EPS (Basic) slumped 285.5% — and 2025, when it jumped 93.98%.
- Relay Therapeutics' EPS (Basic) stood at -$0.67 in 2022, then slumped by 31.64% to -$0.88 in 2023, then tumbled by 285.5% to -$3.39 in 2024, then surged by 93.98% to -$0.2 in 2025, then plunged by 115.17% to -$0.44 in 2026.
- Business Quant data shows RLAY's EPS (Basic) at -$0.44 in Q1 2026, -$0.2 in Q4 2025, and -$0.43 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - | -0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.42 |
| Mar 31, 2026 | -0.44 |
| Dec 31, 2025 | -0.20 |
| Sep 30, 2025 | -0.43 |
| Jun 30, 2025 | -0.43 |
| Mar 31, 2025 | -0.46 |
| Dec 31, 2024 | -3.39 |
| Sep 30, 2024 | -0.63 |
| Jun 30, 2024 | -0.70 |
| Mar 31, 2024 | -0.63 |
| Dec 31, 2023 | -0.88 |
| Sep 30, 2023 | -0.61 |
| Jun 30, 2023 | -0.92 |
| Mar 31, 2023 | -0.83 |
| Dec 31, 2022 | -0.67 |
| Sep 30, 2022 | -0.77 |
| Jun 30, 2022 | -0.85 |
| Mar 31, 2022 | -0.74 |
| Dec 31, 2021 | -0.71 |
| Sep 30, 2021 | -0.66 |